Epidermal growth factor receptors: Critical mediators of multiple receptor pathways

Current Opinion in Cell Biology

Volumn 11, Issue 2, 1999, Pages 184-189

  Hackel, Peter O ^a   Zwick, Esther ^a   Prenzel, Norbert ^a   Ullrich, Axel ^a  

^a MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; LIGAND; PROTEIN SERINE THREONINE KINASE; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE PHOSPHATASE; RECEPTOR; TRANSCRIPTION FACTOR;

APOPTOSIS; CELL COMMUNICATION; CELL GROWTH; DIMERIZATION; MEDIATOR; MOLECULAR INTERACTION; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; TRANSACTIVATION;

EID: 0032915392     PISSN: 09550674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0955-0674(99)80024-6     Document Type: Article

References (65)

1. Guy P.M., Platko J.V., Cantley L.C., Cerione R.A., Carraway K.L. Jr. Insect cell-expressed p180erbB3 possesses an impaired tyrosine kinase activity. Proc Natl Acad Sci USA. 91:1994;8132-8136.
2. Earp H.S., Dawson T.L., Li X., Yu H. Heterodimerization and functional interaction between EGF receptor family members:a new signaling paradigm with implications for breast cancer research. Breast Cancer Res Treat. 35:1995;115-132.
3. Karunagaran D., Tzahar E., Beerli R.R., Chen X., Graus-Porter D., Ratzkin B.J., Seger R., Hynes N.E., Yarden Y. ErbB-2 is a common auxiliary subunit of NDF and EGF receptors:implications for breast cancer. EMBO J. 15:1996;254-264.
4. Tzahar E., Waterman H., Chen X., Levkowitz G., Karunagaran D., Lavi S., Ratzkin B.J., Yarden Y. A hierarchical network of interreceptor interactions determines signal transduction by Neu differentiation factor/neuregulin and epidermal growth factor. Mol Cell Biol. 16:1996;5276-5287.
5. Riese D.J. Jr., Stern D.F. Specificity within the EGF family/ErbB receptor family signaling network. Bioessays. 20:1998;41-48.
6. Okada S., Kao A.W., Ceresa B.P., Blaikie P., Margolis B., Pessin J.E. The 66-kDa isoform is a negative regulator of the epidermal growth factor-stimulated mitogen-activated protein kinase pathway. J Biol Chem. 272:1997;28042-28049.
7. Migliaccio E., Mele S., Salcini A.E., Pelicci G., Lai K.M.V., Superti-Furga G., Pawson T., DiFiore P.P., Lanfranco L., Pelicci P.G. Opposite effects of the p52shc/p46shc and p66shc splicing isoforms on the EGF receptor-MAP kinase-fos signalling pathway. EMBO J. 16:1997;706-716. The authors describe the cloning of the p66Shc isoform, which differs from p52Shc/46Shc by an additional amino-terminal collagen homologous region (CH2). In contrast to p52/46Shc, p66Shc has an inhibitory effect on fos promoter activation upon EGF stimulation and the isolated CH2 domain retains this inhibitory effect.
8. Galcheva-Gargova Z., Konstantinov K.N., Wu I.H., Klier F.G., Barrett T., Davis R.J. Binding of zinc finger protein ZPR1 to the epidermal growth factor receptor. Science. 272:1996;1797-1802.
9. Galisteo M.L., Dikic I., Batzer A.G., Langdon W.Y., Schlessinger J. Tyrosine phosphorylation of the c-cbl proto-oncogene protein product and association with epidermal growth factor (EGF) receptor upon EGF stimulation. J Biol Chem. 270:1995;20242-20245.
10. Levkowitz G., Klapper L.N., Tzahar E., Freywald A., Sela M., Yarden Y. Coupling of the c-cbl proto-oncogene product to ErbB1/EGF-receptor but not to other ErbB proteins. Oncogene. 12:1996;1117-1125.
11. Thien C.B.F., Langdon W.Y. Tyrosine kinase activity of the EGF receptor is enhanced by the expression of oncogenic 70Z-Cbl. Oncogene. 15:1997;2909-2919.
12. Yoon C.H., Lee J., Jongeward G.D., Sternberg P.W. Similarity of sli-1, a regulator of vulval development in C. elegans, to the mammalian proto-oncogene c-cbl. Science. 269:1995;1102-1105.
13. Yarden Y., Schlessinger J. Epidermal growth factor induces rapid, reversible aggregation of purified epidermal growth factor receptors. Biochemistry. 26:1987;1443-1445.
14. Greenfield C., Hiles I., Waterfield M.D., Federwisch M., Wollmer A., Blundell T.L., McDonald N. Epidermal growth factor binding induces a conformational change in the external domain of its receptor. EMBO J. 8:1989;4115-4123.
15. Gullick W. A new model for the interaction of EGF-like ligands with their receptors:the new one-two. Eur J Cancer. 30A:1994;2186.
16. Tzahar E., Pinkas-Kramarski R., Moyer J.D., Klapper L.N., Alroy I., Levkowitz G., Shelly M., Henis S., Eisenstein M., Ratzkin B.J.et al. Bivalence of EGF-like ligands drives the ErbB signaling network. EMBO J. 16:1997;4938-4950. Using an EGF-NDF chimera and isoforms of NDF/neuregulin the authors show the existence of two receptor binding sites in the ligand molecule. The high-affinity amino-terminal site mediates binding to the primary receptor, whereas the carboxy-terminal low-affinity site has broad specificity.
17. Lemmon M.A., Bu Z., Ladbury J.E., Zhou M., Pinchasi D., Lax I., Engelman D.M., Schlessinger J. Two EGF molecules contribute additively to stabilization of the EGFR dimer. EMBO J. 16:1997;281-294.
18. Habib A.A., Högnason T., Ren J., Stefansson K., Ratan R.R. The epidermal growth factor receptor associates with and recruits phosphatidylinositol 3-kinase to the platelet-derived growth factor β receptor. J Biol Chem. 273:1998;6885-6891.
19. Graus-Porta D., Beerli R.R., Daly J.M., Hynes N.E. ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling. EMBO J. 16:1997;1647-1655. Using single-chain-antibody mediated downregulation of cell surface EGFR family receptors it is shown that dimerization follows a strict hierarchy with HER (ErbB2) being the preferred partner for the other members of the family; moreover, HER (ErbB2) is involved in lateral transmission of the signals between EGFR-related receptors.
20. Slikowski M.X., Schaefer G., Akita R.W., Lofgren J.A., Fitzpatrick V.D., Nuijens A., Fendly B.M., Cerione R.A., Vandlen R.L., Carraway K.L. Jr. Coexpression of ErbB2 and ErbB3 proteins reconstitutes a high affinity receptor for heregulin. J Biol Chem. 269:1994;14661-14665.
21. Riese D.J. Jr., vanRaaij T.M., Plowman G.D., Andrews G.C., Stern D.F. The cellular response to neuregulins is governed by complex interactions of the ErbB receptor family. Mol Cell Biol. 15:1995;5770-5776.
22. Elenius K., Paul S., Allison G., Sun J., Klagsbrun M. Activation of HER4 by heparin-binding EGF-like growth factor stimulates chemotaxis but not proliferation. EMBO J. 16:1997;1268-1278. The authors demonstrate that HB-EGF can activate two EGFR subtypes, HER1 and HER4, but with different biological responses. HB-EGF mediated HER1 activation was shown to stimulate proliferation and chemotaxis, whereas activation of HER4 induces only chemotaxis.
23. Linseman D.A., Bejamin C.W., Jones D.A. Convergence of angiotensin II and platelet-derived growth factor receptor signaling cascades in vascular smooth muscle cells. J Biol Chem. 270:1995;12563-12568.
24. Rao G.N., Delafontaine P., Runge M.S. Thrombin stimulates phosphorylation of insulin-like growth factor-1 receptor, insulin receptor substrate-1, and phopholipase C-γ1 in rat aortic smooth muscle cells. J Biol Chem. 270:1995;27871-27875.
25. Weiss F.U., Daub H., Ullrich A. Novel mechanism of RTK signal generation. Curr Opin Genet Dev. 7:1997;80-86.
26. King C.R., Borrello I., Porter L., Comoglio P., Schlessinger J. Ligand-independent tyrosine phosphorylation of EGF receptor and the erbB-2/neu proto-oncogene product is induced by hyperosmotic shock. Oncogene. 4:1989;13-18.
27. Coffer P.J., Burgering B.M., Peppelenbosch M.P., Bos J.L., Kruijer W. UV activation of receptor tyrosine kinase activity. Oncogene. 11:1995;561-569.
28. Knebel A., Rahmsdorf H.J., Ullrich A., Herrlich P. Dephosphorylation of receptor tyrosine kinases as target of regulation by radiation, oxidants or alkylating agents. EMBO J. 15:1996;5314-5325.
29. Daub H., Weiss F.U., Wallasch C., Ullrich A. Role of transactivation of the EGF receptor in signalling by G protein-coupled receptors. Nature. 379:1996;557-560.
30. Gutkind J.S. The pathways connecting G protein-coupled receptors to the nucleus through divergent mitogen-activated protein kinase cascades. J Biol Chem. 273:1998;1839-1842.
31. i-coupled receptors to the MAP kinase pathway in diverse cell types using a selective EGFR inhibitor and a dominant-negative EGFR truncation mutant. Several downstream elements of GPCR and RTK signals are identified and discussed in detail.
32. Rosen L.B., Greenberg M.E. Stimulation of growth factor receptor signal transduction by activation of voltage-sensitive calcium channels. Proc Natl Acad Sci USA. 93:1996;1113-1118.
33. Zwick E., Daub H., Aoki N., Yamaguchi-Aoki Y., Tinhofer I., Maly K., Ullrich A. Critical role of calcium-dependent epidermal growth factor receptor transactivation in PC12 cell membrane depolarization and bradykinin signaling. J Biol Chem. 272:1997;24767-24770. Using a dominant-negative EGFR mutant in conjunction with a tetracycline-sensitive promoter system we could show that bradykinin- and membrane-depolarization- induced activation of the MAP kinase pathway requires EGFR function in PC12 cells. EGFR transactivation upon both stimuli is critically dependent on the presence of extracellular calcium.
34. 12 mediates signaling from lysophosphatidic acid receptor via epidermal growth factor receptor to rho. J Biol Chem. 273:1998;4653-4659.
35. Tsai W., Morielli A.D., Peralta E.G. The m1 muscarinic acetylcholine receptor transactivates the EGF receptor to modulate ion channel activity. EMBO J. 16:1997;4597-4605.
36. Li X., Lee J.W., Graves L.M., Earp H.S. Angiotensin II stimulates ERK via two pathways in epithelial cells:protein kinase C suppresses a G-protein coupled receptor-EGF receptor transactivation pathway. EMBO J. 17:1998;2574-2583. In this study, it was demonstrated that Angiotensin II stimulates ERK via two different pathways in liver epithelial cells: an EGFR- and Ras-independent but PKC-dependent pathway in naive control cells and an EGFR- and Ras-dependent pathway when PKC activation is prevented by an inhibitor or PKC depletion.
37. Luttrell L.M., DellaRocca G.J., vanBiesen T., Luttrell D.K., Lefkovitz R.J. Gβγ subunits mediate Src-dependent phosphorylation of the epidermal growth factor receptor. J Biol Chem. 272:1997;4637-4644.
38. Yamauchi T., Ueki K., Tobe K., Tamemoto H., Sekine N., Wada M., Honjo M., Takahashi M., Takahashi T., Hirai H.et al. Tyrosine phosphorylation of the EGF receptor by the kinase Jak2 is induced by growth hormone. Nature. 390:1997;91-96. The authors of this paper demonstrate tyrosine phosphorylation of the EGFR by Jak2 upon stimulation with growth hormone (GH). Ectopic expression of the EGFR or its kinase inactive mutant revealed that GH-induced MAP kinase activation and c-fos expression requires tyrosine phosphorylation of the EGFR but not its intrinsic kinase activity.
39. Kretzschmar M., Massagué J. SMADs: mediators and regulators of TGF-β signaling. Curr Opin Genet Dev. 8:1998;103-111.
40. Stolz D.B., Michalopoulos G.K. Synergistic enhancement of EGF, but not HGF, stimulated hepatocyte motility by TGF-β1 in vitro. J Cell Physiol. 170:1997;57-68.
41. Niswander L., Martin G.R. FGF-4 and BMP-2 have opposite effects on limb growth. Nature. 361:1993;68-71.
42. Kretzschmar M., Doody J., Massagué J. Opposing BMP and EGF signalling pathways converge on the TGF-β family mediator Smad1. Nature. 389:1997;618-622. In this study, Smad 1 is shown to be a target of opposing regulatory input through RTKs and RS/TKs. Stimulation of epithelial lung cells with EGF induces a rapid increase in serine phosphorylation of Smad1 by the ERK family of MAP kinases. This phosphorylation in the linker region prevents nuclear accumulation of Smad1. In contrast, BMP-induced serine phosphorylation of Smad1 in the carboxy-terminal domain induces nuclear accumulation.
43. DeCaestecker M.P., Parks W.T., Frank C.J., Castagnino P., Bottaro D.P., Roberts A.B., Lechleider R.J. Smad2 transduces common signals from receptor serine-threonine and tyrosine kinases. Genes Dev. 12:1998;1587-1592.
44. Zhang Y., Feng X.H., Derynck R. Smad3 and Smad4 cooperate with c-Jun/c-Fos to mediate TGF - induced transcription. Nature. 394:1998;909-913.
45. Kato S., Endoh H., Masuhiro Y., Kitamoto T., Uchiyama S., Sasaki H., Masushige S., Gotoh Y., Nishida E., Kawashima H.et al. Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase. Science. 270:1995;1491-1494.
46. Joel P.B., Traish A.M., Lannigan D.A. Estradiol-induced phosphorylation of serine 118 in the estrogen receptor is independent of p42/p44 mitogen-activated protein kinase. J Biol Chem. 273:1998;13317-13323.
47. Tonks N.K., Diltz C.D., Fischer E.H. Purification of the major protein-tyrosine-phosphatases of human placenta. J Biol Chem. 263:1988;6722-6730.
48. Bae Y.S., Kang S.W., Seo M.S., Baines I.C., Tekle E., Chock P.B., Rhee S.G. Epidermal growth factor (EGF)-induced generation of hydrogen peroxide. J Biol Chem. 272:1997;217-221.
49. 2 for platelet-derived growth factor signal transduction. Science. 270:1995;296-299.
50. Lee S.R., Kwon K.S., Kim S.R., Rhee S.G. Reversible inactivation of protein-tyrosine phosphatase 1B in A431 cells stimulated with epidermal growth factor. J Biol Chem. 273:1998;15366-15372.
51. Liu F., Chernoff J. Protein tyrosine phosphatase 1B interacts with and is tyrosine phosphorylated by the epidermal growth factor receptor. Biochem J. 327:1997;139-145.
52. Mauro L.J., Dixon J.E. 'Zip codes' direct intracellular protein tyrosine phosphatases to the correct cellular 'address'. Trends Biochem Sci. 19:1994;151-155.
53. Charest A., Wagner J., Kwan M., Tremblay M.L. Coupling of the murine protein tyrosine phosphatase PEST to the epidermal growth factor (EGF) receptor through a Src homolgy 3 (SH3) domain-mediated association with Grb2. Oncogene. 14:1997;1643-1651.
54. Liu F., Hills D.E., Chernoff J. Direct binding of the proline-rich region of protein tyrosine phosphatase 1B to the Src 3 homology domain of p130cas. J Biol Chem. 271:1996;31290-31295.
55. Shen Y., Schneider G., Cloutier J.F., Veillette A., Schaller M.D. Direct association of protein-tyrosine phosphatase PTP-PEST with paxillin. J Biol Chem. 273:1998;6474-6481.
56. Garton A.J., Burnham M.R., Bouton A.H., Tonks N.K. Association of PTP-PEST with SH3 domain of p130cas; a novel mechanism of protein tyrosine phosphatase substrate recognition. Oncogene. 15:1997;877-885.
57. Ojaniemi M., Vuori K. Epidermal growth factor modulates tyrosine phosphorylation of p130cas. J Biol Chem. 272:1997;25993-25998.
58. Xie H., Pallero M.A., Gupta K., Chang P., Ware M.F., Witke W., Kwiatkowski D.J., Lauffenburger D.A., Murphy-Ullrich J.E., Wells A. EGF receptor regulation of cell motility: EGF induces disassembly of focal adhesions independently of the motility-associated PLCγ signaling pathway. J Cell Sci. 111:1998;615-624.
59. Darnell J.E. STATs and gene regulation. Science. 277:1997;1630-1635.
60. David M., Wong L., Flavell R., Thompson S.A., Wells A., Larner A.C., Johnson G.R. STAT activation by epidermal growth factor (EGF) and amphiregulin. J Biol Chem. 271:1996;9185-9188.
61. Leaman D.W., Pisharody S., Flickinger T.W., Commane M.A., Schlessinger J., Kerr I.M., Levy D.E., Stark G.R. Roles of Jaks in activation of STAT and stimulation of c-fos gene expression by epidermal growth factor. Mol Cell Biol. 16:1996;369-375.
62. Sadowski H.B., Shuai K., Darnell J.E.J., Gilman M.Z. A common nuclear signal transduction pathway activated by growth factor and cytokine receptors. Science. 261:1993;1739-1744.
63. Chin Y.E., Kitagawa M., Kuida K., Flavell R.A., Fu X.Y. Activation of the STAT signaling pathway can cause expression of caspase1 and apoptosis. Mol Cell Biol. 17:1997;5328-5337.
64. Chin Y.E., Kitagawa M., Su W-C.S., You Z-H., Iwamoto Y., Fu X-Y. Cell growth arrest and induction of cyclin dependent kinase inhibitor p21WAF1/CIP1 mediated by STAT1. Science. 272:1996;719-722.
65. Gill G.N., Lazar C.S. Increased phosphotyrosine content and inhibition of proliferation in EGF-treated A431 cells. Nature. 293:1981;305-307.